- Home
- CCD vs AVNS Comparison
CCD vs AVNS Comparison
Compare CCD & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCD
- AVNS
- Stock Information
- Founded
- CCD 2014
- AVNS 2014
- Country
- CCD United States
- AVNS United States
- Employees
- CCD N/A
- AVNS N/A
- Industry
- CCD Trusts Except Educational Religious and Charitable
- AVNS Industrial Specialties
- Sector
- CCD Finance
- AVNS Health Care
- Exchange
- CCD Nasdaq
- AVNS Nasdaq
- Market Cap
- CCD 533.8M
- AVNS 591.9M
- IPO Year
- CCD N/A
- AVNS N/A
- Fundamental
- Price
- CCD $20.66
- AVNS $11.88
- Analyst Decision
- CCD
- AVNS
- Analyst Count
- CCD 0
- AVNS 0
- Target Price
- CCD N/A
- AVNS N/A
- AVG Volume (30 Days)
- CCD 96.1K
- AVNS 419.0K
- Earning Date
- CCD 01-01-0001
- AVNS 08-05-2025
- Dividend Yield
- CCD 10.61%
- AVNS N/A
- EPS Growth
- CCD N/A
- AVNS N/A
- EPS
- CCD N/A
- AVNS N/A
- Revenue
- CCD N/A
- AVNS $689,200,000.00
- Revenue This Year
- CCD N/A
- AVNS N/A
- Revenue Next Year
- CCD N/A
- AVNS $3.42
- P/E Ratio
- CCD N/A
- AVNS N/A
- Revenue Growth
- CCD N/A
- AVNS 1.34
- 52 Week Low
- CCD $16.93
- AVNS $11.21
- 52 Week High
- CCD $24.68
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- CCD 61.28
- AVNS 47.94
- Support Level
- CCD $20.45
- AVNS $11.21
- Resistance Level
- CCD $20.68
- AVNS $12.14
- Average True Range (ATR)
- CCD 0.15
- AVNS 0.39
- MACD
- CCD 0.06
- AVNS 0.02
- Stochastic Oscillator
- CCD 95.00
- AVNS 51.94
About CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.